1. Effect of Moderate Hepatic Impairment on the Pharmacokinetics of Vadadustat, an Oral Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitor. Issue 8 (4th March 2021) Authors: Chavan, Ajit; Burke, Leontia; Sawant, Rishikesh; Navarro‐Gonzales, Pamela; Vargo, Dennis; Paulson, Susan K. Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 8(2021) Page Start: 950 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO2VATE trials. Issue 11 (14th November 2020) Authors: Eckardt, Kai-Uwe; Agarwal, Rajiv; Farag, Youssef Mk; Jardine, Alan G; Khawaja, Zeeshan; Koury, Mark J; Luo, Wenli; Matsushita, Kunihiro; McCullough, Peter A; Parfrey, Patrick; Ross, Geoffrey; Sarnak, Mark J; Vargo, Dennis; Winkelmayer, Wolfgang C; Chertow, Glenn M Journal: Nephrology dialysis transplantation Issue: Volume 36:Issue 11(2021) Page Start: 2039 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MO539HEMATOLOGIC EFFICACY OF VADADUSTAT FOR ANEMIA IN PATIENTS WITH KIDNEY FAILURE ON DIALYSIS. (29th May 2021) Authors: Winkelmayer, Wolfgang; Tumlin, James A; Fishbane, Steven; Farag, Youssef; Vargo, Dennis; Luo, Wenli; Koury, Mark Journal: Nephrology dialysis transplantation Issue: Volume 36(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MO541HEMATOLOGIC EFFICACY OF VADADUSTAT FOR ANEMIA IN PATIENTS WITH NON--DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE. (29th May 2021) Authors: Koury, Mark; Pergola, Pablo E; Roy-Chaudhury, Prabir; Farag, Youssef; Vargo, Dennis; Luo, Wenli; Winkelmayer, Wolfgang Journal: Nephrology dialysis transplantation Issue: Volume 36(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SO050DIFFERENT FERRIC CITRATE DOSE REGIMENS IN THE TREATMENT OF IRON DEFICIENCY ANAEMIA IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CKD: THE COMPASS TRIAL. (6th June 2020) Authors: Pergola, Pablo; Belo, Diogo; Crawford, Paul; Moustafa, Moustafa; Vargo, Dennis; Luo, Wenli; Goldfarb-Rumyantezev, Alexander Journal: Nephrology dialysis transplantation Issue: Volume 35(2020)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese patients. Issue 7 (28th July 2020) Authors: Nangaku, Masaomi; Farag, Youssef M K; deGoma, Emil; Luo, Wenli; Vargo, Dennis; Khawaja, Zeeshan Journal: Nephrology dialysis transplantation Issue: Volume 36:Issue 7(2021) Page Start: 1244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗